Dana Pizzuti

Companies

• Crinetics PharmaceuticalsChief Development Officer Oct 11, 2022 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Crinetics Pharmaceuticals66,837 shares²Dec 1, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Dec 1, 2025Sold 5,000 shares at $45.02 of Crinetics Pharmaceuticals²
• Dec 1, 2025Exercised options 5,000 shares at $16.89 of Crinetics Pharmaceuticals²
• Nov 3, 2025Sold 100 shares at $43.27 of Crinetics Pharmaceuticals³
• Nov 3, 2025Sold 4,900 shares at $42.65 of Crinetics Pharmaceuticals³
• Nov 3, 2025Exercised options 5,000 shares at $16.89 of Crinetics Pharmaceuticals³
• Oct 1, 2025Sold 5,000 shares at $41.81 of Crinetics Pharmaceuticals⁴
• Oct 1, 2025Exercised options 5,000 shares at $16.89 of Crinetics Pharmaceuticals⁴
• Sep 2, 2025Sold 5,000 shares at $32.10 of Crinetics Pharmaceuticals⁵
• Sep 2, 2025Exercised options 5,000 shares at $16.89 of Crinetics Pharmaceuticals⁵
• Aug 22, 2025Sold 30,000 shares at $30.43 of Crinetics Pharmaceuticals⁶
• Aug 22, 2025Exercised options 30,000 shares at $16.89 of Crinetics Pharmaceuticals⁶
• Aug 20, 2025Sold 6,492 shares at $29.18 of Crinetics Pharmaceuticals⁷
• Mar 19, 2025Sold 127 shares at $34.83 of Crinetics Pharmaceuticals⁸
• Mar 19, 2025Sold 2,388 shares at $34.17 of Crinetics Pharmaceuticals⁸
• Feb 20, 2025Granted 43,000 shares of Crinetics Pharmaceuticals⁹
• Feb 3, 2025Sold 5,000 shares at $39.07 of Crinetics Pharmaceuticals¹⁰
• Feb 3, 2025Exercised options 5,000 shares at $16.89 of Crinetics Pharmaceuticals¹⁰
• Jan 7, 2025Exercised options 2,500 shares at $19.64 of Crinetics Pharmaceuticals¹¹
• Jan 3, 2025Sold 15,000 shares at $52.09 of Crinetics Pharmaceuticals¹¹
• Jan 3, 2025Exercised options 15,000 shares at $16.89 of Crinetics Pharmaceuticals¹¹
• Oct 3, 2024Sold 14,375 shares at $54.63 of Crinetics Pharmaceuticals¹²
• Oct 3, 2024Exercised options 14,375 shares at $16.89 of Crinetics Pharmaceuticals¹²
• Jul 3, 2024Sold 14,375 shares at $44.87 of Crinetics Pharmaceuticals¹³
• Jul 3, 2024Exercised options 14,375 shares at $16.89 of Crinetics Pharmaceuticals¹³
• Jun 24, 2024Sold 9,500 shares at $45.73 of Crinetics Pharmaceuticals¹⁴